The Cardiovascular Safety of Tumour Necrosis Factor Inhibitors in Arthritic Conditions: A Structured Review with Recommendations.

Rheumatol Ther · 2025 · PMC11920476 · PMID 40019616

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In a separate report, the same researchers found the risk of MI significantly decreased with etanercept among patients with PsA or plaque psoriasis (HR 0.53, 95% CI 0.31–0.92); the reduction in the risk of MI with other TNFis was similar in magnitude but did not reach statistical significance (HR 0.53, 95% CI 0.27–1.06) [ 108 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.